Corporate Profile & Company Profile

Company nameOSferionBiomaterials Corp.
RepresentativeManabu Ishikawa, President
Head OfficeDaiwa Sasazuka Tower, 1-50-1 Sasazuka, Shibuya-ku, Tokyo 151-0073, Japan
Business activitiesResearch and development, manufacture and sale of biomaterials(artificial bones etc.), metal implants and related treatment support systems
Capitalization100,000,000 yen
Shareholder

OrthoActiVolution Holdings, Inc. 

(a wholly owned subsidiary of Polaris Capital Group Co., Ltd.)

Business commencementOctober 1, 2004
Employees127(as of August 1,2025)
OfficersPresident Manabu Ishikawa
Vice President Takao Tabata
Director Eiji Shimizu
Director Ryoichi Ogawa
Director Naohiko Ohno
Director Masashi Matsumoto
Auditor Ryota Kikkawa
Auditor Yuto Sakagami
Financing bankSumitomo Mitsui Banking Corporation、Kiraboshi Bank, Ltd.


Company History 
Sep. 2004 :Established Olympus Biomaterial Corp. 
Sep. 2005 :Acquired HAp technologies from Sumitomo Osaka Cement Co., Ltd.
Dec. 2006 :Concluded the joint venture agreement with Terumo Corporation. 
Jan. 2007 :Opened the manufacturing facility in Mishima, Shizuoka
Apr. 2007 :Changed the name to Olympus Terumo Biomaterials Corp. 
Dec. 2007 :Acquired ISO 13485 certification 
Jul. 2009 :Opened Logistics Center in Shinagawa, Tokyo 
May 2015 :Opened the second Logistics Center in Fukuoka, Kyushu 
Jun. 2015 :Launched our own HTO Plate System successfully, expanding the portfolio of the orthopedic metal implants 
Feb. 2016 :Moved the Head Office to Sasazuka, Tokyo 
Mar. 2017 :Get MDSAP certificate 
Aug. 2020 :Mishima Factory Research and Development Center Acquired ISO14001 
Jul. 2023 :GC Co., Ltd. takes over the development, manufacturing, and sales of collagen products and the sales of dental products.
Aug. 2023 :Becoming a wholly owned subsidiary of Olympus 
Jul. 2024 :Parent company changed to Polaris Capital Group Co., Ltd. 
Aug. 2025 :Merged with PTCJ-6O Holdings Inc.
             Company name changed to OSferionBiomaterials Corp.